1. Home
  2. SNY vs UMH Comparison

SNY vs UMH Comparison

Compare SNY & UMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • UMH
  • Stock Information
  • Founded
  • SNY 1994
  • UMH 1968
  • Country
  • SNY France
  • UMH United States
  • Employees
  • SNY N/A
  • UMH N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • UMH Real Estate Investment Trusts
  • Sector
  • SNY Health Care
  • UMH Real Estate
  • Exchange
  • SNY Nasdaq
  • UMH Nasdaq
  • Market Cap
  • SNY 113.4B
  • UMH 1.3B
  • IPO Year
  • SNY N/A
  • UMH N/A
  • Fundamental
  • Price
  • SNY $47.68
  • UMH $15.03
  • Analyst Decision
  • SNY Buy
  • UMH Buy
  • Analyst Count
  • SNY 4
  • UMH 2
  • Target Price
  • SNY $61.50
  • UMH $20.25
  • AVG Volume (30 Days)
  • SNY 2.8M
  • UMH 666.7K
  • Earning Date
  • SNY 10-24-2025
  • UMH 11-03-2025
  • Dividend Yield
  • SNY 3.35%
  • UMH 5.98%
  • EPS Growth
  • SNY 118.56
  • UMH N/A
  • EPS
  • SNY 8.65
  • UMH 0.13
  • Revenue
  • SNY $53,714,621,258.00
  • UMH $250,046,000.00
  • Revenue This Year
  • SNY $1.53
  • UMH $6.77
  • Revenue Next Year
  • SNY $7.06
  • UMH $5.32
  • P/E Ratio
  • SNY $5.52
  • UMH $117.79
  • Revenue Growth
  • SNY 15.65
  • UMH 8.49
  • 52 Week Low
  • SNY $44.73
  • UMH $14.76
  • 52 Week High
  • SNY $60.12
  • UMH $20.42
  • Technical
  • Relative Strength Index (RSI)
  • SNY 47.66
  • UMH 34.85
  • Support Level
  • SNY $46.50
  • UMH $14.76
  • Resistance Level
  • SNY $47.69
  • UMH $15.44
  • Average True Range (ATR)
  • SNY 0.69
  • UMH 0.27
  • MACD
  • SNY -0.10
  • UMH 0.02
  • Stochastic Oscillator
  • SNY 49.44
  • UMH 27.32

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

Share on Social Networks: